These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 34181477)
1. Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for Nyuykonge B; van Amelsvoort L; Eadie K; Fahal AH; Verbon A; van de Sande W Antimicrob Agents Chemother; 2021 Aug; 65(9):e0043321. PubMed ID: 34181477 [TBL] [Abstract][Full Text] [Related]
2. Development and Validation of an Abd Algaffar SO; Verbon A; van de Sande WWJ; Khalid SA Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318015 [TBL] [Abstract][Full Text] [Related]
3. Lau SK; Lo GC; Lam CS; Chow WN; Ngan AH; Wu AK; Tsang DN; Tse CW; Que TL; Tang BS; Woo PC Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031205 [TBL] [Abstract][Full Text] [Related]
4. Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma. Nyuykonge B; Siddig EE; Mhmoud NA; Nyaoke BA; Zijlstra EE; Verbon A; Bakhiet S; Fahal AH; van de Sande WWJ Mycoses; 2022 Dec; 65(12):1170-1178. PubMed ID: 36005544 [TBL] [Abstract][Full Text] [Related]
5. The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo. Konings M; Eadie K; Strepis N; Nyuykonge B; Fahal AH; Verbon A; van de Sande WWJ Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37960934 [TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs. Pfaller JB; Messer SA; Hollis RJ; Diekema DJ; Pfaller MA J Clin Microbiol; 2003 Mar; 41(3):1126-9. PubMed ID: 12624040 [TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine. van Belkum A; Fahal AH; van de Sande WW Antimicrob Agents Chemother; 2011 Apr; 55(4):1771-3. PubMed ID: 21263050 [TBL] [Abstract][Full Text] [Related]
8. In vitro antifungal activity of isavuconazole against Madurella mycetomatis. Kloezen W; Meis JF; Curfs-Breuker I; Fahal AH; van de Sande WW Antimicrob Agents Chemother; 2012 Nov; 56(11):6054-6. PubMed ID: 22964246 [TBL] [Abstract][Full Text] [Related]
9. Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole. Ozkutuk A; Ergon C; Metin DY; Yucesoy M; Polat SH J Chemother; 2008 Feb; 20(1):87-92. PubMed ID: 18343749 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species. Wang HC; Hsieh MI; Choi PC; Wu CJ J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolates. Pfaller M; Boyken L; Hollis R; Kroeger J; Messer S; Tendolkar S; Diekema D J Clin Microbiol; 2011 Mar; 49(3):1110-2. PubMed ID: 21209166 [TBL] [Abstract][Full Text] [Related]
12. Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole. van de Sande WW; de Kat J; Coppens J; Ahmed AO; Fahal A; Verbrugh H; van Belkum A Microbes Infect; 2007 Jul; 9(9):1114-23. PubMed ID: 17644456 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of microdilution and disk diffusion methods for the detection of fluconazole and voriconazole susceptibility against clinical Candida glabrata isolates and determination of changing susceptibility with new CLSI breakpoints]. Hazırolan G; Sarıbaş Z; Arıkan Akdağlı S Mikrobiyol Bul; 2016 Jul; 50(3):428-37. PubMed ID: 27525398 [TBL] [Abstract][Full Text] [Related]
15. Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species. Al-Hatmi AM; Normand AC; Ranque S; Piarroux R; de Hoog GS; Meletiadis J; Meis JF Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795379 [TBL] [Abstract][Full Text] [Related]
16. Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim. Lim W; Eadie K; Konings M; Rijnders B; Fahal AH; Oliver JD; Birch M; Verbon A; van de Sande W J Antimicrob Chemother; 2020 Apr; 75(4):936-941. PubMed ID: 31904836 [TBL] [Abstract][Full Text] [Related]
17. Comparison of E-Test, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes. Méndez CC; Serrano MC; Valverde A; Pemán J; Almeida C; Martín-Mazuelos E Med Mycol; 2008 Mar; 46(2):119-23. PubMed ID: 18324490 [TBL] [Abstract][Full Text] [Related]
18. [In vitro antifungal activity of azoles and amphotericin B against Malassezia furfur by the CLSI M27-A3 microdilution and Etest Galvis-Marín JC; Rodríguez-Bocanegra MX; Pulido-Villamarín ADP; Castañeda-Salazar R; Celis-Ramírez AM; Linares-Linares MY Rev Iberoam Micol; 2017; 34(2):89-93. PubMed ID: 28214276 [TBL] [Abstract][Full Text] [Related]
19. Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method. van de Sande WW; Luijendijk A; Ahmed AO; Bakker-Woudenberg IA; van Belkum A Antimicrob Agents Chemother; 2005 Apr; 49(4):1364-8. PubMed ID: 15793113 [TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus. Idelevich EA; Groß U; Becker K; Bader O Diagn Microbiol Infect Dis; 2018 May; 91(1):52-54. PubMed ID: 29422272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]